InvestorsHub Logo
Followers 63
Posts 7614
Boards Moderated 1
Alias Born 01/02/2003

Re: L0tsaluck2000 post# 94272

Saturday, 10/15/2016 10:24:30 AM

Saturday, October 15, 2016 10:24:30 AM

Post# of 430692
L..."Is there any data on script volume for Amrn reps versus Kowa reps?"

The relationship between Kowa and Amarin is scheduled to end in 2018. The data on script volume may have a role determining whether it would be useful for Amarin and Kowa to continue the relationship This would be a worthwhile topic for discussion at the next C.C. I imagine that Kowa reps have been successful in detailing Kowa's Lovastatin and I hope they have been equally successful in detailing Amarin's Vascepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News